opioid antagonist, a drug that blocks mu, kappa, or delta opioid receptors, used primarily in the treatment of opioid-induced mu receptor-mediated respiratory depression. The opioid antagonist naloxone is administered parenterally, whereas naltrexone is administered orally.
